BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29885274)

  • 1. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
    Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
    Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
    Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
    Pampalakis G; Sotiropoulou G
    Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer.
    Stuardo-Parada A; López-Muñoz R; Villarroel-Espindola F; Figueroa CD; Ehrenfeld P
    Med Oncol; 2023 Jul; 40(8):224. PubMed ID: 37405520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms.
    Koumandou VL; Scorilas A
    PLoS One; 2013; 8(7):e68074. PubMed ID: 23874499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.
    Yoon H; Blaber SI; Li W; Scarisbrick IA; Blaber M
    Biol Chem; 2013 Jan; 394(1):137-47. PubMed ID: 23241590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
    Mukai S; Fukushima T; Naka D; Tanaka H; Osada Y; Kataoka H
    FEBS J; 2008 Mar; 275(5):1003-17. PubMed ID: 18221492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers.
    Kontos CK; Scorilas A
    Clin Chem Lab Med; 2012 Nov; 50(11):1877-91. PubMed ID: 23093268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology.
    Shaw JL; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):681-8. PubMed ID: 18627298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer.
    Di Meo A; Wang C; Cheng Y; Diamandis EP; Yousef GM
    Biol Chem; 2018 Sep; 399(9):973-982. PubMed ID: 29604203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil.
    Lizama AJ; Andrade Y; Colivoro P; Sarmiento J; Matus CE; Gonzalez CB; Bhoola KD; Ehrenfeld P; Figueroa CD
    Innate Immun; 2015 Aug; 21(6):575-86. PubMed ID: 25563717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.
    Emami N; Diamandis EP
    Clin Chem; 2008 Oct; 54(10):1600-7. PubMed ID: 18687738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological and pathological roles of kallikrein-related peptidases in the epidermis.
    Kishibe M
    J Dermatol Sci; 2019 Aug; 95(2):50-55. PubMed ID: 31279501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interrelationships between the kallikrein-related peptidases family and the classical kinin system in the human neutrophil.
    Ehrenfeld P; Bhoola KD; Matus CE; Figueroa CD
    Biol Chem; 2018 Sep; 399(9):925-935. PubMed ID: 29883315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
    Ehrenfeld P; Manso L; Pavicic MF; Matus CE; Borquez C; Lizama A; Sarmiento J; Poblete MT; Bhoola KD; Naran A; Figueroa CD
    Anticancer Res; 2014 Dec; 34(12):6925-38. PubMed ID: 25503118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
    Avgeris M; Mavridis K; Scorilas A
    Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdependence of kallikrein-related peptidases in proteolytic networks.
    Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
    Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
    Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
    Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and activity of glycosylated KLKs 3, 4 and 11.
    Guo S; Briza P; Magdolen V; Brandstetter H; Goettig P
    Biol Chem; 2018 Sep; 399(9):1009-1022. PubMed ID: 29975661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.
    Filippou PS; Karagiannis GS; Musrap N; Diamandis EP
    Crit Rev Clin Lab Sci; 2016 Aug; 53(4):277-91. PubMed ID: 26886390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.